Table 5.
Primary endpoints and other clinical events during follow-up according to ATRIA score tertiles
| ATRIA 0 (n=417) | ATRIA 1-2 (n=598) | ATRIA ≥3 (n=612) | P value | |
|---|---|---|---|---|
| Primary endpoints | ||||
| Death/MI/CVE | 32 (7.7%) | 92 (15.4%) | 158 (25.8%) | <0.001 |
| All-cause death | 2 (0.5%) | 37 (6.2%) | 85 (13.9%) | <0.001 |
| In-hospital mortality | 0 (0%) | 21 (3.5%) | 38 (6.2%) | <0.001 |
| Myocardial infarction | 30 (7.2%) | 60 (10.1%) | 84 (13.8%) | 0.003 |
| CVE | 0 (0%) | 4 (0.7%) | 3 (0.5%) | 0.26 |
| Hospitalization | 43 (10.3%) | 97 (16.3%) | 124 (20.3%) | <0.001 |
| Contrast-induced acute kidney injury | 45 (10.8%) | 95 (15.9%) | 141 (23%) | <0.001 |
| Definite ST during follow-up, (early or late) | 5 (1.2%) | 6 (1%) | 12 (2%) | 0.33 |
| Stent restenosis during follow-up | 22 (5.3%) | 40 (6.7%) | 35 (5.7%) | 0.61 |
CVE - cerebrovascular event, MI - myocardial infarction; PCI - percutaneous coronary intervention, ST - stent thrombosis